Precigen (PGEN) 2025 Earnings Outlook: What to Watch
As biotech earnings season unfolds, Precigen (PGEN) 2025 earnings take center stage. This guide breaks down what to m...
This intro explains glide path asset allocation, describing how asset mix automatically becomes more conservative as you age.
24,533 articlesAs biotech earnings season unfolds, Precigen (PGEN) 2025 earnings take center stage. This guide breaks down what to m...
Bitcoin briefly climbs above $81,000 as on-chain profits hit a cycle high, prompting traders to weigh the risk of a s...
As PacBio lays out its Q1 2026 results, investors hunt for catalysts, cadence, and cash runway signals. This guide tr...
Investors are watching Health Catalyst as healthcare data analytics gain budget priority. This guide breaks down what...
IMDX kicked off 2026 with a solid Q1 showing, delivering revenue growth and improving margins while guiding higher fu...
Long-dated U.S. Treasuries saw muted appetite from investors as inflation remains stubborn and energy risks persist. ...
A leading retailer is quietly deploying AI to sharpen efficiency and customer service, signaling a stealth AI play fo...
The White House rolled back Biden-era refrigerant limits affecting grocery stores and HVAC equipment, saying it will ...
A hidden wrinkle in Social Security planning could shake up your retirement budget. This article breaks down what to ...
Salesforce is set to release Q1 results as investors look for evidence that its AI strategy can rekindle growth. A re...
A 50-person consultancy hired its first full-stack developer this January as Meta cuts thousands of jobs and AI resha...
Credo Technology faces a pivotal Q4 print as analysts and traders dissect margins, inventory builds, and AI demand si...